Peptide library · 15 compounds
Weight & metabolic peptides
GLP-1, GIP, glucagon and amylin agonists and other metabolic compounds, approved and investigational.
- AOD-9604Anti-Obesity Drug FragmentA modified fragment of human growth hormone (HGH) that retains the fat-burning properties without the growth-promoting or blood sugar…Research compound
- CagrilintideAM833Cagrilintide is a long-acting amylin analogue developed by Novo Nordisk. It is the amylin component of CagriSema and is also under…Phase 3 trials
- CagriSemaCagrilintide + Semaglutide CombinationA fixed-dose combination of two peptides — cagrilintide (an amylin analog) and semaglutide (GLP-1 agonist). Targets two different hunger…Submitted to FDA
- EfpeglenatideLAPS-Exendin4Efpeglenatide is a long-acting exendin-based GLP-1 receptor agonist fused to an antibody Fc fragment, developed by Hanmi and later…Phase 3 trials
- LiraglutideGLP-1 Receptor Agonist (Daily)One of the first GLP-1 receptor agonists approved for weight management. Requires daily injection but has the longest safety track…FDA approved
- MazdutideIBI362, LY3305677Mazdutide is a GLP-1 and glucagon receptor dual agonist based on the oxyntomodulin backbone, developed by Innovent and licensed from Eli…Approved outside the U.S.
- OrforglipronOral GLP-1 Receptor AgonistThe first small-molecule GLP-1 pill, and the only one with no food or water restrictions. A daily pill from Eli Lilly (brand Foundayo)…FDA approved
- OxyntomodulinOXMOxyntomodulin is a naturally occurring gut hormone produced from the same proglucagon precursor as GLP-1, acting at both the GLP-1 and…Research compound
- PemvidutideDual GLP-1/Glucagon AgonistAn investigational dual-agonist peptide targeting both GLP-1 and glucagon receptors. Being developed by Altimmune with particular focus…Phase 2 trials
- Peptide YYPYY 3-36, PYYPeptide YY is a gut hormone released from intestinal L cells after a meal, and one of the principal endogenous satiety signals. PYY 3-36…Research compound
- RetatrutideTriple GLP-1/GIP/Glucagon AgonistThe most anticipated next-generation weight management peptide. Activates three hormone receptors simultaneously — GLP-1, GIP, and…Phase 3 trials
- SemaglutideGLP-1 Receptor AgonistMimics a natural gut hormone (GLP-1) that tells your brain you're full and slows stomach emptying. Originally developed for type 2…FDA approved
- SetmelanotideImcivreeSetmelanotide is a melanocortin-4 receptor agonist approved in the US to reduce excess body weight and maintain weight reduction long…FDA approved
- SurvodutideDual GLP-1/Glucagon AgonistA dual-action peptide from Boehringer Ingelheim that combines GLP-1 and glucagon receptor activation. Takes a different approach than…Phase 3 trials
- TirzepatideDual GIP/GLP-1 AgonistA newer dual-action peptide that activates both GIP and GLP-1 receptors. Works on two appetite pathways simultaneously for enhanced…FDA approved
Other categories
Track what you actually take.
Peptide Vault logs every dose, reminds you on your schedule and keeps your vials organized. It never recommends doses. iPhone, on-device.